Johnson Health Tech .Co., Ltd. (TPE:1736)
197.00
-9.50 (-4.60%)
Mar 31, 2025, 1:35 PM CST
Johnson Health Tech .Co. Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 2,430 | 709.83 | 429.02 | 38.15 | 679.29 | Upgrade
|
Depreciation & Amortization | 1,487 | 1,367 | 1,182 | 1,018 | 966.9 | Upgrade
|
Other Amortization | 34.95 | 31.49 | 24.47 | 22.49 | 17.11 | Upgrade
|
Loss (Gain) From Sale of Assets | 6.32 | 9.05 | 2.54 | -4.52 | 8.03 | Upgrade
|
Loss (Gain) From Sale of Investments | -13.57 | -3.84 | 0.28 | 5.9 | -25.97 | Upgrade
|
Stock-Based Compensation | 4.66 | - | - | 4.35 | 0.71 | Upgrade
|
Provision & Write-off of Bad Debts | 192.97 | 137.27 | 18.4 | 384.24 | 51.6 | Upgrade
|
Other Operating Activities | 532.94 | 450.26 | -281.44 | -168.63 | 127.3 | Upgrade
|
Change in Accounts Receivable | -2,824 | -1,876 | -1,180 | -937.17 | 860.65 | Upgrade
|
Change in Inventory | -2,761 | 2,769 | -134.18 | -3,728 | -666.89 | Upgrade
|
Change in Accounts Payable | 1,662 | -202.49 | 111.91 | -145.67 | 803.7 | Upgrade
|
Change in Unearned Revenue | 372.87 | 89.83 | 27.24 | 0.23 | 355.55 | Upgrade
|
Change in Other Net Operating Assets | -71.73 | 361.62 | 192.23 | -25.72 | -236.19 | Upgrade
|
Operating Cash Flow | 1,054 | 3,843 | 392.45 | -3,537 | 2,942 | Upgrade
|
Operating Cash Flow Growth | -72.58% | 879.11% | - | - | 211.88% | Upgrade
|
Capital Expenditures | -673.78 | -649.99 | -407.78 | -692.04 | -781.49 | Upgrade
|
Sale of Property, Plant & Equipment | 49.82 | 25.88 | 24.02 | 35.29 | 10.07 | Upgrade
|
Cash Acquisitions | - | - | -251.44 | - | -1,760 | Upgrade
|
Sale (Purchase) of Intangibles | -52.62 | -57.15 | -33.08 | -65.64 | -53.07 | Upgrade
|
Investment in Securities | 5.46 | - | - | - | - | Upgrade
|
Investing Cash Flow | -670.84 | -680.82 | -667.73 | -721.78 | -2,583 | Upgrade
|
Short-Term Debt Issued | 45,221 | 41,425 | 61,402 | 15,606 | 17,211 | Upgrade
|
Long-Term Debt Issued | 17,165 | 17,841 | 1,611 | 593.97 | 1,268 | Upgrade
|
Total Debt Issued | 62,386 | 59,266 | 63,013 | 16,200 | 18,480 | Upgrade
|
Short-Term Debt Repaid | -44,015 | -48,984 | -59,954 | -10,574 | -16,442 | Upgrade
|
Long-Term Debt Repaid | -18,213 | -13,972 | -1,921 | -1,280 | -1,351 | Upgrade
|
Total Debt Repaid | -62,227 | -62,956 | -61,875 | -11,855 | -17,794 | Upgrade
|
Net Debt Issued (Repaid) | 158.78 | -3,689 | 1,138 | 4,346 | 686.2 | Upgrade
|
Issuance of Common Stock | 30.13 | - | 20.26 | - | 6.27 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -32.31 | Upgrade
|
Common Dividends Paid | -302.92 | -181.75 | -151.29 | -338.9 | -424.16 | Upgrade
|
Other Financing Activities | - | - | -160.8 | -23.48 | -653.85 | Upgrade
|
Financing Cash Flow | -114.02 | -3,871 | 846.52 | 3,983 | -417.85 | Upgrade
|
Foreign Exchange Rate Adjustments | 76.62 | -480.79 | 345.23 | -402.08 | 71.87 | Upgrade
|
Net Cash Flow | 345.31 | -1,190 | 916.48 | -677.72 | 12.32 | Upgrade
|
Free Cash Flow | 379.78 | 3,193 | -15.32 | -4,229 | 2,160 | Upgrade
|
Free Cash Flow Growth | -88.10% | - | - | - | 630.50% | Upgrade
|
Free Cash Flow Margin | 0.80% | 8.39% | -0.05% | -13.74% | 7.62% | Upgrade
|
Free Cash Flow Per Share | 1.25 | 10.54 | -0.05 | -13.98 | 7.14 | Upgrade
|
Cash Interest Paid | 329.74 | 407.15 | 222.81 | 115.35 | 109.2 | Upgrade
|
Cash Income Tax Paid | 549.28 | 144.71 | 189.39 | 342.31 | 222.77 | Upgrade
|
Levered Free Cash Flow | -635.71 | 2,661 | -603.28 | -4,105 | 1,151 | Upgrade
|
Unlevered Free Cash Flow | -417.08 | 2,897 | -443.16 | -4,003 | 1,253 | Upgrade
|
Change in Net Working Capital | 3,212 | -1,430 | 1,075 | 4,386 | -521.62 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.